RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
about
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerRole of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysemaRLIP76: a versatile transporter and an emerging target for cancer therapy.RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.Therapeutic resistance in lung cancer.Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76RLIP76: A novel glutathione-conjugate and multi-drug transporter.Regression of prostate cancer xenografts by RLIP76 depletion.RLIP76 and Cancer.Physiological and pharmacological significance of glutathione-conjugate transport.RLIP76 Targeted Therapy for Kidney CancerMitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.P300 regulates the human RLIP76 promoter activity and gene expressionRlip depletion prevents spontaneous neoplasia in TP53 null mice.Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.
P2860
Q24533543-9C5C9DA9-ABD2-4B0D-98DC-2EE7CD25100DQ28396304-09AA7A7D-B95C-4B7E-9BA0-EEB913FA919DQ30051796-2B72BBF6-BC13-4DE1-99C2-03626AA79363Q30429404-E0C6D9B2-F202-4406-97EB-EC36285F9D08Q33867008-E3C48A81-6490-4406-AFEC-D01CE2C460CAQ34023922-F524EBF9-7843-4A9A-9148-7DEBBC51203BQ34556062-12901A06-A10A-47DE-A1B7-A1C7BC34AECEQ36609767-7A0728A7-A4BF-4759-AE4D-939CD0F90E6CQ36744205-8D709659-D6A4-4606-8EE8-1DB1913C6DF8Q36982690-D86AC3C0-137C-4D66-B7F0-2BE87E9BDB67Q37146979-4A636AB5-19AD-4AD1-A8EF-BECE12EBE084Q37194622-8DBAB05D-4A63-4E3C-998A-EE41C0570F7DQ37217140-877005B8-0416-44F6-A478-DA9F184DC0A4Q37698426-458515EE-BC1C-4C3D-ADD4-B48E517A06F3Q37741408-4CE51847-F14A-49F9-8CE6-F305CC4256D3Q40247154-0655F5B8-41A0-4023-B7AE-3ED69CCF1442Q40297526-D69D18F3-CF25-4D55-9155-36CCFFE98500Q40387322-06635BAA-274E-4F77-A6C5-EA125A9ADA3EQ42051924-D05BB82D-EBDE-4D89-85CE-81D9626F0743Q52724571-78CDD228-0DC3-4FD2-89A2-7D5413EF455FQ53793272-EEEAC3E5-E221-465E-983B-DA2DBB02E348
P2860
RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
RLIP76 (RALBP1)-mediated trans ...... plications in drug resistance.
@en
type
label
RLIP76 (RALBP1)-mediated trans ...... plications in drug resistance.
@en
prefLabel
RLIP76 (RALBP1)-mediated trans ...... plications in drug resistance.
@en
P2093
P356
P1476
RLIP76 (RALBP1)-mediated trans ...... plications in drug resistance.
@en
P2093
Dilki Wickramarachchi
Rajendra Sharma
Sanjay Awasthi
Sharad S Singhal
Yogesh C Awasthi
P304
P356
10.1002/IJC.20516
P577
2004-12-01T00:00:00Z